Media contact: Lissa Quirino, pr@3tbiosciences.com 3T Biosciences Appoints Industry Veteran John Connolly as Interim CEODecember 16, 2020High Throughput Technology Drives Developments in Personalized Cancer Immuno-therapiesJune 9, 2020Forbes: 3T BiosciencesMay 5, 2020Peter Thiel Among Investors Who Helped 3T Biosciences Close a $12 Million Funding RoundOctober 7, 2017Peter Thiel and Sean Parker are financing a secretive cancer-fighting start-up, source saysOctober 4, 2017
